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et al., 2003; Schroeder et al., 2005), 
but whether any of these compounds 
will surmount the significant obstacles 
required to enter the clinic remains 
to be seen. The important findings 
reported by Paik et al. and Tothova et 
al. have substantially contributed to 
our understanding of FoxO proteins 
and illuminate the complexity of their 
function. Moreover, the generation of 
these animals in which FoxO inactiva-
tion can be executed in a controlled 
manner will allow other fundamental 
questions to be addressed.
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Although guanylyl cyclases have been implicated in cell migration, how they are activated 
to promote cell motility is unknown. In this issue, Guo et al. (2007) report direct commu-
nication between guanylyl cyclases and the Rac-p21-activated kinase (PAK) signaling 
pathway—which is essential for cell migration—to promote cell motility, through allosteric 
activation of guanylyl cyclases by autophosphorylated PAK.Cell motility is a complex biological 
process that requires the precisely 
coordinated function of numerous 
cellular proteins. Fundamentally, 
motility requires two elements—sig-
nal transduction pathways that are 
activated in response to stimuli that 
induce motility and cellular compo-
nents that mediate the mechanical 
aspects of motility. With regard to 
signaling pathways, much evidence 
supports an essential role for some 
of the Rho-family GTPases (and 
many of their upstream regulators 
and downstream effectors) as well 
as several receptor kinases, G pro-
tein-coupled receptors, and a vari-
ety of additional intracellular signal-
ing proteins and scaffolds. Among 
the many proteins required for the 
mechanical aspects of cell motil-
ity are components of the actomy-osin cytoskeleton, microtubules, 
integrins, and a variety of cytoskel-
etal binding proteins. Numerous 
studies have begun to elucidate sig-
naling pathways that link cell sur-
face receptors (engaged by known 
chemotactic ligands) and integrins 
to intracellular pathways that pro-
mote the coordinated cytoskeletal 
reorganization required for proper 
cell movement. In addition to the 
various cell-migration proteins that 
have been linked to specific cellu-
lar pathways, there are additional 
proteins that appear to be required 
for motility but whose specific 
function has been elusive. A good 
example of such a class of proteins 
is the family of guanylyl cyclases, 
which catalyze the conversion of 
GTP to the second messenger 
cyclic GMP (cGMP). In particular, Cell 128, Jathe transmembrane subclass of 
guanylyl cyclases—whose activity 
can be modulated by intracellular 
signals via membrane-associated 
receptors—has been implicated 
in chemotactic cell migration and 
axon guidance (Ayoob et al., 2004; 
Bosgraaf et al., 2002). Moreover, 
cGMP has also been implicated 
in cell motility, along with a few 
cGMP-dependent kinases and 
phosphodiesterases (Postma et 
al., 2004). However, a signaling 
pathway wherein guanylyl cyclases 
are activated in the context of cell 
migration has not been established. 
In this issue, Guo et al. (2007) reveal 
a signaling link between the Rac 
GTPase and the transmembrane 
guanylyl cyclases that mediates 
growth factor-induced migration of 
fibroblasts.nuary 26, 2007 ©2007 Elsevier Inc. 237
Guo et al. (2007) set out to iden-
tify signaling proteins that pro-
mote guanylyl cyclase activity. 
They determined that an activated 
form of Rac1 GTPase—but not the 
related Rho or Cdc42 GTPases— 
stimulates guanylyl cyclase activity 
in transfected cells. This effect of 
Rac1 specifically involved trans-
membrane, not soluble, guanylyl 
cyclases. The authors went on to 
demonstrate that PDGF (plate-
let-derived growth factor)—which 
promotes cell migration via the 
Rac GTPase—stimulates guanylyl 
cyclase activity, thereby integrating 
the guanylyl cyclases with a known 
cell-motility signaling pathway.
Rac GTPases mediate their bio-
logical activities through direct 
interactions with a variety of pro-
tein effectors. By examining several 
of the known effectors, Guo et al. 
(2007) identified the p21-activated 
kinase (PAK) as a critical mediator 
of Rac-stimulated guanylyl cyclase 
activity. Moreover, activated PAK 
could substitute for Rac to pro-
mote guanylyl cyclase activity and 
consequent cGMP accumulation. 
Previous studies strongly support 
a critical role for Rac-PAK signal-
ing in cell migration in a variety of 
experimental systems. Additionally, 
several downstream effectors of 
activated PAK have been linked to 
its role in motility, including myosin, 
the PIX/COOL guanine nucleotide 
exchange factors, the LIM-kinases, 
the Merlin tumor suppressor, and 
Filamin A (Bokoch, 2003). These 
new findings implicate the guanylyl 
cyclases as additional PAK effec-
tors in cell motility.
Interestingly, although PAK kinase 
activity was found to be required 
for its ability to promote guanylyl 
cyclase activity, guanylyl cyclases 
do not appear to be phosphor-
ylated by activated PAK. Further in 
vitro biochemical analysis revealed 
that autophosphorylated PAK binds 
directly to guanylyl cyclase and 
promotes its activity. Specifically, 
the kinase domain of PAK interacts 
directly with the cyclase domain of 
guanylyl cyclases. The authors were 238 Cell 128, January 26, 2007 ©2007 Elsalso able to demonstrate in vitro 
using purified proteins that acti-
vated Rac promotes a conforma-
tion change in PAK that enables it to 
bind to guanylyl cyclases and pre-
sumably to promote a subsequent 
conformational change in the guan-
ylyl cyclase that leads to activation. 
They suggest that this may be anal-
ogous to the previously established 
allosteric regulation of adenylyl 
cyclases by G proteins (Dumas and 
Lambright, 1998). This mechanism 
of activation might also be related 
to recent structural studies of the 
EGF receptor demonstrating that 
the EGF receptor kinase domain 
can promote activation of a dimer-
ized EGF receptor partner in the 
absence of catalytic activity through 
an allosteric mechanism (Zhang et 
al., 2006). The authors also suggest 
that their findings may be relevant to 
previous studies that demonstrated 
a kinase-independent function for 
PAKs in membrane ruffling (Frost 
et al., 1998) and neurite outgrowth 
(Daniels et al., 1998). However, the 
fact that PAK autophosphorylation 
appears to be required for its ability 
to activate guanylyl cyclases seems 
to support the involvement of its 
catalytic function and therefore 
distinguishes the proposed mecha-
nism from mechanisms implied by 
findings with kinase-deficient PAK.
To establish a functional role 
of the Rac-PAK-guanylyl cyclase 
signaling cascade in the context 
of cell motility, the authors used 
small interfering RNA to examine 
the consequences of reducing gua-
nylyl cyclase expression on PDGF-
induced fibroblast migration. In 
both wound-healing and Boyden 
chamber assays, cells depleted of 
guanylyl cyclase activity exhibited 
reduced PDGF-stimulated motility. 
Moreover, the ability of activated 
Rac to promote motility in these 
cells was also diminished follow-
ing guanylyl cyclase knockdown. 
The authors also determined that 
Rac-PAK-guanylyl cyclase signal-
ing is important for the production 
of lamellipodia, the actin-rich mem-
brane protrusive structures formed evier Inc.at the leading edge of migrating 
cells. Notably, guanylyl cyclase 
activity is not required for estab-
lishing cell polarity, another cellu-
lar process in which Rac and PAK 
have been implicated and that plays 
a role in directional cell migration. 
Thus, Rac-PAK-guanylyl cyclase 
signaling may be required for a sub-
set of Rac-mediated cytoskeletal 
reorganization processes required 
for cell migration.
These new findings certainly add 
another intriguing layer of complex-
ity to the regulation of a cellular 
process that has already presented 
a big challenge to cell biologists. 
They also leave several critical 
questions open for future study. 
What are the targets of cGMP that 
are critical to Rac-mediated cell 
motility? Does spatially compart-
mentalized signaling explain why 
Cdc42, which also activates PAK, 
fails to promote guanylyl cyclase 
activation? Which of the many bio-
logical processes in which Rac and 
PAK have been implicated require 
Rac-PAK-guanylyl cyclase signal-
ing? Consequently, it will be quite 
some time before cell biologists can 
PAK up and go home.
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